WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (96)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bakshi, V. P.
Right arrow Articles by Geyer, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bakshi, V. P.
Right arrow Articles by Geyer, M. A.

 Previous Article  |  Next Article 

The Journal of Neuroscience, October 15, 1998, 18(20):8394-8401

Multiple Limbic Regions Mediate the Disruption of Prepulse Inhibition Produced in Rats by the Noncompetitive NMDA Antagonist Dizocilpine

Vaishali P. Bakshi1 and Mark A. Geyer1, 2

1 Program in Neurosciences and 2 Department of Psychiatry, University of California at San Diego, La Jolla, California 92093

Prepulse inhibition (PPI), a phenomenon in which a weak prestimulus decreases the startle response to an intense stimulus, provides an operational measure of sensorimotor gating (a process by which an organism filters sensory information) and is diminished in schizophrenia and schizotypal patients. The psychotomimetic phencyclidine and its potent congener dizocilpine are noncompetitive antagonists of the NMDA receptor complex, and they disrupt PPI in rodents, mimicking the clinically observed PPI deficit. The neuroanatomical substrates mediating the PPI-disruptive effects of noncompetitive NMDA antagonists are unknown. The present study sought to identify brain regions subserving the disruption of PPI produced by noncompetitive NMDA antagonists in rats. PPI was measured in startle chambers immediately after bilateral infusion of dizocilpine (0, 0.25, 1.25, and 6.25 µg/0.5 µl/side) into one of six brain regions: amygdala, dorsal hippocampus, medial prefrontal cortex, nucleus accumbens, ventral hippocampus, and dorsomedial thalamus. Dizocilpine significantly decreased PPI after infusion into the amygdala or dorsal hippocampus. A trend toward PPI disruption was observed with administration into medial prefrontal cortex. In contrast, no change in PPI was produced by dizocilpine infusion into nucleus accumbens, ventral hippocampus, or dorsomedial thalamus. Startle reactivity was increased by dizocilpine infusion into amygdala, dorsal hippocampus, nucleus accumbens, and dorsomedial thalamus, but not medial prefrontal cortex. These findings indicate that multiple limbic forebrain regions mediate the ability of noncompetitive NMDA antagonists to disrupt PPI and that the PPI-disruptive and the startle-increasing effects of dizocilpine are mediated by different central sites.

Key words: startle; prepulse inhibition; schizophrenia; dizocilpine; MK-801; glutamate; phencyclidine; amygdala; nucleus accumbens; medial prefrontal cortex; hippocampus; dorsomedial thalamus


Copyright © 1998 Society for Neuroscience  0270-6474/98/18208394-08$05.00/0


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
A. E. Khalifa
Neural monoaminergic mediation of the effect of St. John's wort extract on prepulse inhibition of the acoustic startle response in rats
J Psychopharmacol, September 1, 2005; 19(5): 467 - 472.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
V. Kumari, E. Zachariah, A. Galea, H. C. Jones, M. Das, R. Mehrotra, D. Taylor, and T. Sharma
Effects of acute procyclidine administration on prepulse inhibition of the startle response in schizophrenia: a double-blind, placebo-controlled study
J Psychopharmacol, January 1, 2003; 17(1): 89 - 95.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
J. N. C. Kew, A. Koester, J.-L. Moreau, F. Jenck, A.-M. Ouagazzal, V. Mutel, J. G. Richards, G. Trube, G. Fischer, A. Montkowski, et al.
Functional Consequences of Reduction in NMDA Receptor Glycine Affinity in Mice Carrying Targeted Point Mutations in the Glycine Binding Site
J. Neurosci., June 1, 2000; 20(11): 4037 - 4049.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
V. P. Bakshi, M. Tricklebank, H. C. Neijt, V. Lehmann-Masten, and M. A. Geyer
Disruption of Prepulse Inhibition and Increases in Locomotor Activity by Competitive N-Methyl-D-aspartate Receptor Antagonists in Rats
J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 643 - 652.
[Abstract] [Full Text]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-